Zymeworks (ZYME) Cash from Operations (2021 - 2026)
Zymeworks' (ZYME) quarterly Cash from Operations came in at 45718000.0 in Q1 2026, down 1241.88% year-on-year from 4003732.93 in Q1 2025, and down 345.64% quarter-over-quarter from 10259000.0 in Q4 2025.
Zymeworks (ZYME) Cash from Operations (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Cash from Operations across 6 years of filings, most recently posting 45718000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 45718000.0, down 1241.88% year-over-year; the trailing twelve-month figure through Mar 2026 was 75316000.0 (up 0.63% YoY), and the FY2025 annual result was 33005000.0, up 70.01% from the prior year.
- Cash from Operations came in at 45718000.0 for Q1 2026 at Zymeworks, down from 10259000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 327360000.0 in Q4 2022 to a low of 83191000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 31412000.0 (2025), against an average of 9588000.0.
- Across the five-year window, Cash from Operations jumped 748.12% in 2022 and plunged 1241.88% in 2026, its largest moves.
- Zymeworks' Cash from Operations stood at 327360000.0 in 2022, then slumped by 95.74% to 13933000.0 in 2023, then sank by 397.93% to 41510000.0 in 2024, then jumped by 75.29% to 10259000.0 in 2025, then sank by 345.64% to 45718000.0 in 2026.
- The last three Cash from Operations figures came in at 45718000.0 (Q1 2026), 10259000.0 (Q4 2025), and 31412000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -45.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.72 Mn |
| Mar 31, 2026 | -45.72 Mn |
| Dec 31, 2025 | -10.26 Mn |
| Dec 31, 2025 | -10.26 Mn |
| Sep 30, 2025 | -31.41 Mn |
| Sep 30, 2025 | -31.41 Mn |
| Jun 30, 2025 | 12.07 Mn |
| Jun 30, 2025 | 12.07 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Mar 31, 2024 | -37.68 Mn |
| Mar 31, 2024 | -37.68 Mn |
| Dec 31, 2023 | 13.93 Mn |
| Dec 31, 2023 | 13.93 Mn |